Literature DB >> 27096309

Opportunities and challenges in leveraging electronic health record data in oncology.

Marc L Berger1, Melissa D Curtis2, Gregory Smith1, James Harnett1, Amy P Abernethy2.   

Abstract

The widespread adoption of electronic health records (EHRs) and the growing wealth of digitized information sources about patients is ushering in an era of 'Big Data' that may revolutionize clinical research in oncology. Research will likely be more efficient and potentially more accurate than the current gold standard of manual chart review studies. However, EHRs as they exist today have significant limitations: important data elements are missing or are only captured in free text or PDF documents. Using two case studies, we illustrate the challenges of leveraging the data that are routinely collected by the healthcare system in EHRs (e.g., real-world data), specific challenges encountered in the cancer domain and opportunities that can be achieved when these are overcome.

Entities:  

Keywords:  clinical research; electronic health records; real-world data

Mesh:

Year:  2016        PMID: 27096309     DOI: 10.2217/fon-2015-0043

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  30 in total

1.  Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.

Authors:  Sean Khozin; Amy P Abernethy; Nathan C Nussbaum; Jizu Zhi; Melissa D Curtis; Melisa Tucker; Shannon E Lee; David E Light; Anala Gossai; Rachael A Sorg; Aracelis Z Torres; Payal Patel; Gideon Michael Blumenthal; Richard Pazdur
Journal:  Oncologist       Date:  2018-01-09

2.  Leveraging the health information technology infrastructure to advance federal research priorities.

Authors:  Teresa Zayas-Cabán; Amy P Abernethy; Patricia Flatley Brennan; Stephanie Devaney; Anthony R Kerlavage; Rachel Ramoni; P Jon White
Journal:  J Am Med Inform Assoc       Date:  2020-04-01       Impact factor: 4.497

3.  Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.

Authors:  Jeremy M O'Connor; Kristen L Fessele; Jean Steiner; Kathi Seidl-Rathkopf; Kenneth R Carson; Nathan C Nussbaum; Emily S Yin; Kerin B Adelson; Carolyn J Presley; Anne C Chiang; Joseph S Ross; Amy P Abernethy; Cary P Gross
Journal:  JAMA Oncol       Date:  2018-08-09       Impact factor: 31.777

4.  Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core.

Authors:  Melisa L Wong; Stuart M Lichtman; Gary R Morrow; John Simmons; Tomma Hargraves; Cary P Gross; Jennifer L Lund; Lisa M Lowenstein; Louise C Walter; Cara L McDermott; Supriya G Mohile; Harvey Jay Cohen
Journal:  J Geriatr Oncol       Date:  2019-07-17       Impact factor: 3.599

5.  Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Authors:  Stephen J Bagley; Suzanna Talento; Nandita Mitra; Neal J Meropol; Roger B Cohen; Corey J Langer; Anil Vachani
Journal:  J Natl Compr Canc Netw       Date:  2019-05-01       Impact factor: 11.908

Review 6.  The opportunities and shortcomings of using big data and national databases for sarcoma research.

Authors:  Heather G Lyu; Adil H Haider; Adam B Landman; Chandrajit P Raut
Journal:  Cancer       Date:  2019-05-15       Impact factor: 6.860

7.  Validity of Natural Language Processing for Ascertainment of EGFR and ALK Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.

Authors:  Bernardo Haddock Lobo Goulart; Emily T Silgard; Christina S Baik; Aasthaa Bansal; Qin Sun; Eric B Durbin; Isaac Hands; Darshil Shah; Susanne M Arnold; Scott D Ramsey; Ramakanth Kavuluru; Stephen M Schwartz
Journal:  JCO Clin Cancer Inform       Date:  2019-05

8.  Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.

Authors:  Sean Khozin; Kenneth R Carson; Jizu Zhi; Melisa Tucker; Shannon E Lee; David E Light; Melissa D Curtis; Marta Bralic; Irene Kaganman; Anala Gossai; Philip Hofmeister; Aracelis Z Torres; Rebecca A Miksad; Gideon Michael Blumenthal; Richard Pazdur; Amy P Abernethy
Journal:  Oncologist       Date:  2018-12-27

9.  What Oncologists Want: Identifying Challenges and Preferences on Diagnosis Data Entry to Reduce EHR-Induced Burden and Improve Clinical Data Quality.

Authors:  Franck Diaz-Garelli; Roy Strowd; Tamjeed Ahmed; Thomas W Lycan; Sean Daley; Brian J Wells; Umit Topaloglu
Journal:  JCO Clin Cancer Inform       Date:  2021-05

10.  Building External Control Arms From Patient-Level Electronic Health Record Data to Replicate the Randomized IMblaze370 Control Arm in Metastatic Colorectal Cancer.

Authors:  Carsten Schröder; Marcus Lawrance; Chen Li; Christelle Lenain; Shivani K Mhatre; Marwan Fakih; Irmarie Reyes-Rivera; Michael T Bretscher
Journal:  JCO Clin Cancer Inform       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.